Gene-based Drug Design

Scientist to discuss ssDNA expression system in targeting, silencing genes

Published in Gene Therapy Weekly, July 10th, 2003

Yin Chen, CytoGenix (CYGX) vice president, R&D, and chief scientific officer, has been invited to speak at the 3rd International Conference on RNA in Drug Development to be held in San Diego in November 2003.

Chen will present the results of preclinical studies using the company's proprietary ssDNA expression system in targeting and silencing genes. This meeting brings together world leaders in the field of gene-based drug design to explore recent advances in this exciting new approach to developing therapeutic compounds. CytoGenix has developed formulations against herpes, several inflammatory diseases, E. coli, Staphylococcus, and strep.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2003-07-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry